NCT00954044 Exercising Together: An Intervention for Prostate Cancer Survivors and Spouses Status COMPLETED Phase NA
NCT00953576 Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00953277 Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer Status COMPLETED Phase PHASE4
NCT00953225 Vitamin D Supplementation in Veterans With Early-Stage Prostate Cancer Status COMPLETED Phase PHASE2
NCT00952666 Transrectal Ultrasound Imaging of the Prostate Gland and Neurovascular Bundles During Robot-Assisted Laparoscopic Radical Prostatectomy Status TERMINATED Phase EARLY_PHASE1
NCT00951535 A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17 Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00949962 Post-operative or Early Salvage XRT and ADT for High Risk PCa Status TERMINATED Phase PHASE3
NCT00949338 Comparing Two Sets of Bladder-Filling Instructions in Treating Patients Undergoing Radiation Therapy For Prostate Cancer. ICORG 05-04 Status COMPLETED Phase NA
NCT00946881 Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00946543 Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer Status UNKNOWN Phase PHASE1
NCT00945477 Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade Status TERMINATED Phase PHASE2
NCT00943956 Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer Status COMPLETED Phase PHASE1
NCT00939510 Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00937833 Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling Status COMPLETED Phase NA
NCT00937417 S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors Status WITHDRAWN Phase PHASE1